Post Feed

PBS Broadens Nivolumab and Ipilimumab Access from 1 March 2026

01 Mar 2026

The broad PBS listing will replace existing item codes for:

Unresectable Stage III or Stage IV melanoma
Locally advanced or metastatic NSCLC
Stage IV clear cell renal cell carcinoma
Recurrent or metastatic squamous cell carcinoma of the oral cavity, pharynx, or larynx
Advanced or metastatic gastro-oesophageal cancers
Unresectable or metastatic urothelial carcinoma

Current PBS items without ‘Supply Only’ arrangements will be removed, and prescriptions for affected indications must be rewritten after 1 March to ensure subsidy and dispensing.

More information is available in the PBS factsheet: [PDF 140KB] |

https://www.pbs.gov.au/

Source: PBS / Department of Health